Síndrome de Cushing iatrogénico por corticoides inhalados en paciente VIH / Cushing syndrome in a HIV patient using inhaled steroids: report of one case
Rev. méd. Chile
;
144(7): 931-936, jul. 2016. ilus, tab
Article
in Spanish
| LILACS
| ID: lil-794007
ABSTRACT
We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Bronchodilator Agents
/
HIV Infections
/
HIV Protease Inhibitors
/
Cushing Syndrome
/
Salmeterol Xinafoate
/
Fluticasone
Type of study:
Diagnostic study
Limits:
Adult
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2016
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Universidad Católica del Maule/CL
Similar
MEDLINE
...
LILACS
LIS